Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia
This trial is active, not recruiting.
|Sponsor||University of Aarhus|
|Start date||February 2011|
|End date||October 2014|
|Trial size||125 participants|
|Trial identifier||NCT01481792, AUH-Ophthalmology-2011-01|
Evaluation of the safety and efficacy of the Carl Zeiss Meditec VisuMax femtosecond laser for lamellar resection (ReLEx smile) in the reduction of myopia.
time frame: Refraction one year after surgery
time frame: One year after surgery
Male or female participants from 18 years up to 80 years old.
Inclusion Criteria: - Indication for keratorefractive correction of myopia - Patient consent to undergo keratorefractive correction of myopia Exclusion Criteria: - Pregnant or lactating women
|Official title||Use of the VisuMax Femtosecond Laser for the Correction of Myopia With Small Incision Lenticular Extraction|
|Description||Quality control study of patients treated with ReLEx smile for myopia at the Department of Ophthalmology, Aarhus University Hospital. The patients will be followed with standard clinical techniques (slit-lamp examination, refraction, topography) during their normal follow-up up to 12 months after treatment.|
Call for more information